Netspot is owned by Aaa Usa Inc.
Netspot contains Gallium Dotatate Ga-68.
Netspot has a total of 1 drug patent out of which 0 drug patents have expired.
Netspot was authorised for market use on 01 June, 2016.
Netspot is available in powder;intravenous dosage forms.
The generics of Netspot are possible to be released after 10 August, 2032.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US9375498||AAA USA INC||Process for the preparation of complexes of 68Ga|| |
(9 years from now)
|Orphan Drug Exclusivity (ODE)||Jun 1, 2023|
Market Authorisation Date: 01 June, 2016
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic